Summary
It has been an active year in the biosimilars marketplace! Goodwin Procter partner Elaine Blais will lead a comprehensive discussion of key biosimilars developments in the past year. Topics to include: market developments for biosimilars; approval pathways and timelines for follow-on biologics in the U.S.; recent legal developments concerning the BPCIA; recent legal developments potentially impacting biosimilars; biosimilars at the FDA; regulation of biosimilars outside of the U.S.; and biosimilars and the PTAB.
Speakers
- /en/people/b/blais-elaine-herrmann
Elaine Herrmann Blais
PartnerCo-Chair, Intellectual Property Litigation